Evidence map›Paper›PMID 30233061›Full record

ArticleNeural regeneration research2018

Inhibition of neurite outgrowth using commercial myelin associated glycoprotein-Fc in neuro-2a cells.

Fu Liu, Mei-Ling Gao, Juan Bai, Ya-Fang Wang, Xia-Qing Li

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fu LiuDepartment of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China.
Mei-Ling GaoDepartment of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province; Department of Vascular Surgery, People's Hospital of Gansu Province, Lanzhou, Gansu Province, China.
Juan BaiDepartment of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China.
Ya-Fang WangDepartment of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China.
Xia-Qing LiDepartment of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China.
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelin-associated glycoprotein (MAG) inhibits the growth of neurites from nerve cells. Extraction and purification of MAG require complex operations; therefore, we attempted to determine whether commercially available MAG-Fc can replace endogenous MAG for research purposes. Immunofluorescence using specific antibodies against MAG, Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PirB) was used to determine whether MAG-Fc can be endocytosed by neuro-2a cells. In addition, neurite outgrowth of neuro-2a cells treated with different doses of MAG-Fc was evaluated. Enzyme linked immunosorbent assays were used to measure RhoA activity. Western blot assays were conducted to assess Rho-associated protein kinase (ROCK) phosphorylation. Neuro-2a cells expressed NgR and PirB, and MAG-Fc could be endocytosed by binding to NgR and PirB. This activated intracellular signaling pathways to increase RhoA activity and ROCK phosphorylation, ultimately inhibiting neurite outgrowth. These findings not only verify that MAG-Fc can inhibit the growth of neural neurites by activating RhoA signaling pathways, similarly to endogenous MAG, but also clearly demonstrate that commercial MAG-Fc is suitable for experimental studies of neurite outgrowth.

Indexed as

cell cultureMAG-Fcmyelin-associated glycoproteinmyelin growth inhibitorsnerve regenerationneural regenerationneurite outgrowthneuro-2a cell linereceptors for myelin-associated glycoproteinRhoA/ROCK signaling pathways

Identifiers

PMID30233061
PMCPMC6183046
OpenAlexW2892228792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.